Literature DB >> 28728844

Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma.

Yejun Liu1, Zezhang Tao2, Jining Qu1, Xuhong Zhou1, Chenghong Zhang1.   

Abstract

While some long noncoding RNAs (lncRNAs) might promote nasopharyngeal carcinoma (NPC) initiation and progression, the involved molecular mechanisms remain largely unclear. Here, we discovered the novel LncRNA, prostate cancer associated transcript 7 (PCAT7), which was overexpressed and associated with worse prognosis in NPC. Decreased PCAT7 expression was found to significantly suppress tumor cell proliferation in vitro, and inhibited tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Rescue assay was performed to further confirm that PCAT7 contributed to the progression of NPC through regulating miR-134-5p/ELF2 signal pathway. These results indicated that PCAT7 might contribute to the tumor progression in NPC by functioning as a ceRNA to sponge miR-134-5p.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ELF2; Nasopharyngeal carcinoma (NPC); Prostate cancer associated transcript 7 (PCAT7); Tumorigenesis; miR-134-5p

Mesh:

Substances:

Year:  2017        PMID: 28728844     DOI: 10.1016/j.bbrc.2017.07.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Ying-Juan Zheng; Jing-Yi Zhao; Tian-Song Liang; Ping Wang; Juan Wang; Dao-Ke Yang; Zhang-Suo Liu
Journal:  FASEB J       Date:  2019-09-26       Impact factor: 5.191

2.  Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.

Authors:  Lu Huang; Xiaoqin Gan; Li He; Luying Wang; Jie Yu
Journal:  Exp Ther Med       Date:  2019-07-19       Impact factor: 2.447

3.  Long non-coding RNA LINC01410 promotes colon cancer cell proliferation and invasion by inhibiting miR-3128.

Authors:  Jihui Luo; Yi Guo; Xiaofei Liu; Xihua Yang; Fangtao Xiao; Meihua Zhou
Journal:  Exp Ther Med       Date:  2018-09-28       Impact factor: 2.447

4.  Circ_0028007 Aggravates the Malignancy of Nasopharyngeal Carcinoma by Regulating miR-656-3p/ELF2 Axis.

Authors:  Xiaojun Ma; Yan Li
Journal:  Biochem Genet       Date:  2022-03-03       Impact factor: 1.890

Review 5.  Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.

Authors:  Rebecca Morgan; Willian Abraham da Silveira; Ryan Christopher Kelly; Ian Overton; Emma H Allott; Gary Hardiman
Journal:  Expert Rev Mol Diagn       Date:  2021-11-25       Impact factor: 5.225

6.  LncRNA PCAT7 promotes non-small cell lung cancer progression by activating miR-486-5p/CDK4 axis-mediated cell cycle.

Authors:  Wenting Geng; Mengru Qiu; Dongbin Zhang; Peng Li; Gangyi Sun; Xi Zhou
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

7.  Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway.

Authors:  Nan Cheng; Yang Guo
Journal:  Onco Targets Ther       Date:  2017-12-11       Impact factor: 4.147

8.  Long Non-Coding RNA Prostate Cancer-Associated Transcript 7 (PCAT7) Induces Poor Prognosis and Promotes Tumorigenesis by Inhibiting mir-134-5p in Non-Small-Cell Lung (NSCLC).

Authors:  Qiongliang Liu; Yingying Wu; Jie Xiao; Jianyong Zou
Journal:  Med Sci Monit       Date:  2017-12-24

9.  A preliminary study of microRNA expression in different types of primary melanoma.

Authors:  Ioana Gencia; Flavia Baderca; Stefania Avram; Armand Gogulescu; Anca Marcu; Edward Seclaman; Catalin Marian; Caius Solovan
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

10.  LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.

Authors:  Dongmei Han; Jianfeng Wang; Guanghui Cheng
Journal:  Oncotarget       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.